In CPhI s 2017 Annual Report , Girish Malhorta, CPhI expert and president of EPCOT International, took a look at revenues of pharmaceuticals around the world to get a perspective on how drug companies may be able to reduce the cost and availability of the drugs they manufacture. Malhorta beliOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.